Oral administration of stearic acid (SA) displayed protective effects in cholestasis-induced liver injury in rats, decreasing the accumulation of leukocytes, MPO activity, activation of NF-κB, and production of transforming growth factor-beta 1 (TGF-β1) [49]. Here, NFKB1 is linked to cholestasis.